NBCC is currently partnering with BioMarin on clinical trials for women with metastatic breast cancer. Intervention offers the potential of improving the length and quality of life for patients already diagnosed with metastatic breast cancer. Trial accrual has begun.
NBCC advocates have been involved in many ways on clinical trials in the development of the protocols, as members of the Date Safety Monitoring Board, as reviewers of educational materials and consent forms and in conducting outreach activities to educate the public about the trials.
NBCC is recruiting advocates to help educate the public and potential participants about these trials. If you are interested in helping NBCC’s outreach effort for any of these trials, please contact us at email@example.com.